Research library / Senolytics

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study

J Justice, A Nambiar, T Tchkonia, N LeBrasseur, R Pascual, S Hashmi et al.. EBioMedicine. 2019.

Published 2026-10-15Sources checked 2026-10-151 sourceEverstack research teamHow we work

In plain language

Dasatinib plus quercetin was feasible and may have improved physical function in lung fibrosis.

Limits

Open label, tiny.

Source

doi.org/10.1016/j.ebiom.2018.12.052 · PubMed 30616998 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack.